🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to Bioptimus, a Sofinnova Partners portfolio company, on achieving a $76 million funding milestone. The latest $41m investment comes less than 12 months from the initial seed round. Learn more: sofinnovapartners.com/news/bioptimus…

Sofinnova Partners portfolio company cure51 is making headlines on Sky News!

Thrilled to see our Partner, Edward Kliphuis, engaging with President Emmanuel Macron at the AI Action Summit in Paris. 🚀🇫🇷 Thanks to everyone who made the Summit a success. We were honored to be part of it.

Congratulations to Latent Labs, a Sofinnova Partners portfolio company, on emerging from stealth with a $50M funding. Latent Labs is developing AI foundation models to make biology programable. Checkout the press release to learn more: sofinnovapartners.com/news/latent-la…

At Sofinnova Partners, we are known for backing entrepreneurs who are solving the world’s most pressing problems across healthcare. However, our work around sustainability has been less in the spotlight. It's time that changed…

Today, we’re spotlighting , on Afyren a Sofinnova Partners portfolio company working on the manufacturing sectors transition to a low-carbon circular industry. If you’d like to learn more about Afyren🌱 , please visit afyren.com

Today, we’re highlighting NOVAMEAT,🍔, a portfolio company working to transform our everyday meals with plant-based meats… If you want to learn more about please visit novameat.com

Micropep 🧬🌽 is on a mission to protect the future of global food production. If you’d like to learn more about the incredible work, they are doing: micro-pep.com

Congratulations to Nanophoria, a Sofinnova Partners portfolio company, on the award of up to €17.5M it received from the European Innovation Council accelerator program. Learn more: hubs.ly/Q038qZDV0

Congratulations to Pi-Cardia, a Sofinnova Partners portfolio company, on performing their first commercial procedures with ShortCut™. Learn more: sofinnovapartners.com/news/pi-cardia…

BIG NEWS: Sofinnova Partners has raised €1.2 billion to drive the next wave of life sciences innovation, bringing total assets under management to over €4 billion. Learn more: sofinnovapartners.com/news/sofinnova…

📈Sofinnova Partners, fonds d’investissement européen spécialisé dans les sciences de la vie, annonce un premier closing de 1,2 milliard d’euros sur sa plateforme d’investissement. Antoine Papiernik, son président, détaille sa stratégie : 👇 maddyness.com/2025/03/04/sof…

Sofinnova Partners raises €1.2B to invest in up to 60 life sciences startups, as European VCs grow their coffers. endpts.com/sofinnova-part…

📰 Sofinnova Partners and Gustave Roussy launch first biotech company through Strategic Partnership. SIGNADORI BIO, a novel cell therapy platform, emerges from collaboration with scientific founders Dr. Jean-Luc PERFETTINI and Professor Nathalie CHAPUT. Read press release ➡

💡 Sofinnova Partners closes its Biovelocita II fund at €165M, with support from Amgen, Bristol Myers Squibb, and Pfizer Ventures! This fund aims to accelerate biotech innovation across Europe, supporting startups in transforming healthcare. 🌍 techfundingnews.com/e165-million-f… #Biotech

It’s official! Sofinnova Partners Biovelocita II has successfully closed above target at €165M, making it the largest pan-European fund for biotech acceleration. Backed by top pharmas Amgen, Bristol Myers Squibb, and Pfizer Inc. ventures. Learn more: sofinnovapartners.com/news/Sofinnova…

Congratulations to SafeHeal, a Sofinnova Partners portfolio company on its oversubscribed €35 million Series C financing. Learn more: sofinnovapartners.com/news/safeheal-…

Congratulations to HAYA Therapeutics on becoming a Sofinnova Partners portfolio company and raising $65 million in its Series A. Learn more: sofinnovapartners.com/news/haya-ther…